SCHEMBL29429644

SCHEMBL29429644

N[C@@H](CCCC(=O)O)C(=O)N[C@H](CC(C(=O)O)C(=O)O)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GNPAT O15228 2/20 0.44
▸ FOLH1 Q04609 4/20 0.43
▸ NOD1 Q9Y239 4/20 0.43
▸ DPP4 P27487 1/20 0.43
▸ DPP8 Q6V1X1 1/20 0.43
▸ DPP9 Q86TI2 1/20 0.43
▸ NAALAD2 Q9Y3Q0 2/20 0.41
▸ RIMKLA Q8IXN7 1/20 0.41
▸ GRM8 O00222 1/20 0.40
▸ GRM6 O15303 1/20 0.40
▸ GRIN2D O15399 1/20 0.40
▸ GRIN3B O60391 1/20 0.40
▸ GSR P00390 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ GRIK1 P39086 1/20 0.40
▸ GRM5 P41594 1/20 0.40
▸ GRIA1 P42261 1/20 0.40
▸ GRIA2 P42262 1/20 0.40
▸ GRIA3 P42263 1/20 0.40
▸ SLC1A3 P43003 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29429642 1.00 GNPAT (0.44) GNPATFOLH1NOD1DPP4DPP8
SCHEMBL29429643 0.92 GNPAT (0.43) GNPATFOLH1NOD1DPP4DPP8
SCHEMBL29429647 0.92 GNPAT (0.51) GNPATFOLH1NOD1DPP4DPP8
SCHEMBL29546590 0.90 DPP4 (0.53) GNPATFOLH1DPP4DPP8DPP9
SCHEMBL29429648 0.89 GNPAT (0.49) GNPATFOLH1NOD1DPP4DPP8
SCHEMBL29429649 0.89 GNPAT (0.49) GNPATFOLH1NOD1DPP4DPP8
SCHEMBL32687011 0.87 FOLH1 (0.54) GNPATFOLH1NOD1DPP4DPP8
SCHEMBL22316504 0.84 FOLH1 (0.54) GNPATFOLH1NOD1DPP4DPP8
SCHEMBL9785114 0.81 FOLH1 (0.63) GNPATFOLH1NOD1DPP8DPP9
SCHEMBL29575698 0.81 FOLH1 (0.39) FOLH1NOD1NAALAD2ENPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12397060-B2 pHLIP®-mediated intracellular delivery of immuno-stimulatory compounds UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) 2025-08-26 — — US disclosed
US-12290575-B2 Fluorescent compound comprising a fluorophore conjugated to a pH-triggered polypeptide UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) 2025-05-06 — — US disclosed
US-20240342296-A1 pH LOW INSERTION PEPTIDE TARGETED DELIVERY OF POTENT CYTOTOXIC COMPOUNDS YALE UNIVERSITY 2024-10-17 — — US disclosed
US-12029793-B2 pH low insertion peptide targeted delivery of potent cytotoxic compounds YALE UNIVERSITY (US) 2024-07-09 — — US disclosed
US-20240148911-A1 FLUORESCENT COMPOUND COMPRISING A FLUOROPHORE CONJUGATED TO A pH-TRIGGERED POLYPEPTIDE UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES 2024-05-09 — — US disclosed
US-20240075170-A1 FLUORESCENT COMPOUND COMPRISING A FLUOROPHORE CONJUGATED TO A pH-TRIGGERED POLYPEPTIDE UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES 2024-03-07 — — US disclosed
US-20240042063-A1 LINKED AND OTHER pH-TRIGGERED COMPOUNDS UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES 2024-02-08 — — US disclosed
US-20230372551-A1 RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2023-11-23 — — US disclosed
US-11779662-B2 Fluorescent compound comprising a fluorophore conjugated to a pH-triggered polypeptide UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) 2023-10-10 — — US disclosed
US-11738096-B2 Method of detecting diseased or damaged tissue with a pH-triggered polypeptide fluorophore composition YALE UNIVERSITY (US) 2023-08-29 — — US disclosed
US-20220088208-A1 PHLIP®-MEDIATED INTRACELLULAR DELIVERY OF IMMUNO-STIMULATORY COMPOUNDS UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) 2022-03-24 — — US disclosed
US-11267853-B2 Carbohydrate tethering at cell surfaces to induce immune response UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) 2022-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240342296-A1 pH LOW INSERTION PEPTIDE TARGETED DELIVERY OF POTENT CYTOTOXIC COMPOUNDS PMAIP1, SCAMP2, CHERP GNPAT 1964/4885FOLH1 1300/4885NOD1 1698/4885
US-11738096-B2 Method of detecting diseased or damaged tissue with a pH-triggered polypeptide fluorophore composition VIP, FUCA1, FGB GNPAT 3612/4885FOLH1 26/4885NOD1 634/4885
US-11267853-B2 Carbohydrate tethering at cell surfaces to induce immune response CD4, CD14, CD69 GNPAT 1449/4885FOLH1 775/4885NOD1 404/4885
US-20220088208-A1 PHLIP®-MEDIATED INTRACELLULAR DELIVERY OF IMMUNO-STIMULATORY COMPOUNDS STING1, MAVS, IRF3 GNPAT 1503/4885FOLH1 1135/4885NOD1 54/4885
US-20240042063-A1 LINKED AND OTHER pH-TRIGGERED COMPOUNDS LIPA, PHOSPHO1, NGLY1 GNPAT 859/4885FOLH1 43/4885NOD1 555/4885
US-20240075170-A1 FLUORESCENT COMPOUND COMPRISING A FLUOROPHORE CONJUGATED TO A pH-TRIGGERED POLYPEPTIDE NPPA, LNPEP, VIP GNPAT 2177/4885FOLH1 10/4885NOD1 743/4885
US-20240148911-A1 FLUORESCENT COMPOUND COMPRISING A FLUOROPHORE CONJUGATED TO A pH-TRIGGERED POLYPEPTIDE NPPA, LNPEP, VIP GNPAT 2177/4885FOLH1 10/4885NOD1 743/4885
US-12397060-B2 pHLIP®-mediated intracellular delivery of immuno-stimulatory compounds STING1, MAVS, IRF3 GNPAT 1503/4885FOLH1 1135/4885NOD1 54/4885
US-12290575-B2 Fluorescent compound comprising a fluorophore conjugated to a pH-triggered polypeptide NPPA, LNPEP, VIP GNPAT 2177/4885FOLH1 10/4885NOD1 743/4885
US-12029793-B2 pH low insertion peptide targeted delivery of potent cytotoxic compounds SLC7A1, SLC47A1, VIP GNPAT 1760/4885FOLH1 501/4885NOD1 2188/4885
US-20230372551-A1 RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE MPI, FOLH1, GRPR GNPAT 1187/4885FOLH1 2/4885NOD1 2636/4885
US-11779662-B2 Fluorescent compound comprising a fluorophore conjugated to a pH-triggered polypeptide NPPA, LNPEP, VIP GNPAT 2177/4885FOLH1 10/4885NOD1 743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback